Glycogen synthase kinase 3 (GSK3 ... Figure 5: Several signalling pathways induce the inhibition of GSK3 by phosphorylating the same serine residue near the amino terminus. Figure 6: The mechanism ...
BIO CEO & Investor Conference Format: "IPO Class of 2024 Panel" and one-on-one meetings Date: February 10, 2025 Location: New York, NY Registered conference attendees may schedule one-on-one meetings ...
Hosted on MSN1mon
EMA gives OMPD to Actuate’s pancreatic cancer therapyActuate Therapeutics has gained orphan medicinal product designation (OMPD) from the European Medicines Agency (EMA) for elraglusib to treat pancreatic ductal adenocarcinoma (PDAC). The glycogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback